436 related articles for article (PubMed ID: 15233757)
1. Antinociceptive effects of N-acetylaspartylglutamate (NAAG) peptidase inhibitors ZJ-11, ZJ-17 and ZJ-43 in the rat formalin test and in the rat neuropathic pain model.
Yamamoto T; Hirasawa S; Wroblewska B; Grajkowska E; Zhou J; Kozikowski A; Wroblewski J; Neale JH
Eur J Neurosci; 2004 Jul; 20(2):483-94. PubMed ID: 15233757
[TBL] [Abstract][Full Text] [Related]
2. Local administration of N-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in peripheral pain in rats.
Yamamoto T; Saito O; Aoe T; Bartolozzi A; Sarva J; Zhou J; Kozikowski A; Wroblewska B; Bzdega T; Neale JH
Eur J Neurosci; 2007 Jan; 25(1):147-58. PubMed ID: 17241276
[TBL] [Abstract][Full Text] [Related]
3. N-antipyrine-3, 4-dichloromaleimide, an effective cyclic imide for the treatment of chronic pain: the role of the glutamatergic system.
Quintão NL; da Silva GF; Antonialli CS; de Campos-Buzzi F; Corrêa R; Filho VC
Anesth Analg; 2010 Mar; 110(3):942-50. PubMed ID: 20185671
[TBL] [Abstract][Full Text] [Related]
4. Potentiation of morphine antiallodynic efficacy by ACPT-III, a group III metabotropic glutamate receptor agonist, in rat spinal nerve ligation-induced neuropathic pain.
Lee HG; Park SK; Yoon MH
Pharmacol Biochem Behav; 2010 Jul; 96(1):108-13. PubMed ID: 20434481
[TBL] [Abstract][Full Text] [Related]
5. Anti-hyperalgesic effects of intrathecally administered neuropeptide W-23, and neuropeptide B, in tests of inflammatory pain in rats.
Yamamoto T; Saito O; Shono K; Tanabe S
Brain Res; 2005 May; 1045(1-2):97-106. PubMed ID: 15910767
[TBL] [Abstract][Full Text] [Related]
6. Analgesic effect of intrathecally administered orexin-A in the rat formalin test and in the rat hot plate test.
Yamamoto T; Nozaki-Taguchi N; Chiba T
Br J Pharmacol; 2002 Sep; 137(2):170-6. PubMed ID: 12208773
[TBL] [Abstract][Full Text] [Related]
7. Analgesic effects of intrathecally administered 26RFa, an intrinsic agonist for GPR103, on formalin test and carrageenan test in rats.
Yamamoto T; Wada T; Miyazaki R
Neuroscience; 2008 Nov; 157(1):214-22. PubMed ID: 18824219
[TBL] [Abstract][Full Text] [Related]
8. NAAG peptidase inhibition reduces locomotor activity and some stereotypes in the PCP model of schizophrenia via group II mGluR.
Olszewski RT; Bukhari N; Zhou J; Kozikowski AP; Wroblewski JT; Shamimi-Noori S; Wroblewska B; Bzdega T; Vicini S; Barton FB; Neale JH
J Neurochem; 2004 May; 89(4):876-85. PubMed ID: 15140187
[TBL] [Abstract][Full Text] [Related]
9. Effects of (S)-3,4-DCPG, an mGlu8 receptor agonist, on inflammatory and neuropathic pain in mice.
Marabese I; de Novellis V; Palazzo E; Scafuro MA; Vita D; Rossi F; Maione S
Neuropharmacology; 2007 Feb; 52(2):253-62. PubMed ID: 17113112
[TBL] [Abstract][Full Text] [Related]
10. NAAG peptidase inhibitor reduces acute neuronal degeneration and astrocyte damage following lateral fluid percussion TBI in rats.
Zhong C; Zhao X; Sarva J; Kozikowski A; Neale JH; Lyeth BG
J Neurotrauma; 2005 Feb; 22(2):266-76. PubMed ID: 15716632
[TBL] [Abstract][Full Text] [Related]
11. Intrathecal ultra-low dose naloxone enhances the antinociceptive effect of morphine by enhancing the reuptake of excitatory amino acids from the synaptic cleft in the spinal cord of partial sciatic nerve-transected rats.
Yang CP; Cherng CH; Wu CT; Huang HY; Tao PL; Wong CS
Anesth Analg; 2011 Dec; 113(6):1490-500. PubMed ID: 21865493
[TBL] [Abstract][Full Text] [Related]
12. Intracerebroventricular administration of N-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in inflammatory pain.
Yamamoto T; Kozikowski A; Zhou J; Neale JH
Mol Pain; 2008 Aug; 4():31. PubMed ID: 18673570
[TBL] [Abstract][Full Text] [Related]
13. The effect of the AMPA/kainate receptor antagonist LY293558 in a rat model of postoperative pain.
Lee HJ; Pogatzki-Zahn EM; Brennan TJ
J Pain; 2006 Oct; 7(10):768-77. PubMed ID: 17018337
[TBL] [Abstract][Full Text] [Related]
14. Antinociceptive effects and synergistic interaction with morphine of intrathecal metabotropic glutamate receptor 2/3 antagonist in the formalin test of rats.
Yoon MH; Choi Jl; Bae HB; Kim SJ; Chung ST; Jeong SW; Chung SS; Yoo KY; Jeong CY
Neurosci Lett; 2006 Feb; 394(3):222-6. PubMed ID: 16293369
[TBL] [Abstract][Full Text] [Related]
15. Anti-allodynic effects of intrathecally and intracerebroventricularly administered 26RFa, an intrinsic agonist for GRP103, in the rat partial sciatic nerve ligation model.
Yamamoto T; Miyazaki R; Yamada T; Shinozaki T
Peptides; 2011 Jun; 32(6):1262-9. PubMed ID: 21439338
[TBL] [Abstract][Full Text] [Related]
16. Pre-versus post-formalin effects of intrathecal ketamine on spinal Fos-like immunoreactivity in rats.
Lee IO; Lee IH; Lee KC
Indian J Med Res; 2004 Dec; 120(6):527-33. PubMed ID: 15654138
[TBL] [Abstract][Full Text] [Related]
17. Divergent peripheral effects of pituitary adenylate cyclase-activating polypeptide-38 on nociception in rats and mice.
Sándor K; Bölcskei K; McDougall JJ; Schuelert N; Reglodi D; Elekes K; Petho G; Pintér E; Szolcsányi J; Helyes Z
Pain; 2009 Jan; 141(1-2):143-50. PubMed ID: 19091468
[TBL] [Abstract][Full Text] [Related]
18. Endogenous N-acetylaspartylglutamate (NAAG) inhibits synaptic plasticity/transmission in the amygdala in a mouse inflammatory pain model.
Adedoyin MO; Vicini S; Neale JH
Mol Pain; 2010 Sep; 6():60. PubMed ID: 20860833
[TBL] [Abstract][Full Text] [Related]
19. A role for the locus coeruleus in the analgesic efficacy of N-acetylaspartylglutamate peptidase (GCPII) inhibitors ZJ43 and 2-PMPA.
Nonaka T; Yamada T; Ishimura T; Zuo D; Moffett JR; Neale JH; Yamamoto T
Mol Pain; 2017 Jan; 13():1744806917697008. PubMed ID: 28326936
[TBL] [Abstract][Full Text] [Related]
20. Antinociceptive effect of intrathecal administration of hypotaurine in rat models of inflammatory and neuropathic pain.
Hara K; Nakamura M; Haranishi Y; Terada T; Kataoka K; Sata T
Amino Acids; 2012 Jul; 43(1):397-404. PubMed ID: 21971909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
